Trial Profile
Clinical Trials Insight: 700030961
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Feb 2008
Price :
$35
*
At a glance
- Drugs INCB 19602 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Incyte Corporation
- 28 Feb 2008 New trial record.